Invech Holdings, Inc. Files S-1 Registration Statement

Ticker: IVHI · Form: S-1 · Filed: Jan 30, 2024 · CIK: 1009919

Invech Holdings, Inc. S-1 Filing Summary
FieldDetail
CompanyInvech Holdings, Inc. (IVHI)
Form TypeS-1
Filed DateJan 30, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$35,000, $50,000, $45,000, $0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: S-1, Registration Statement, Invech Holdings, Public Offering, SEC Filing

TL;DR

<b>Invech Holdings, Inc. has filed an S-1 registration statement for a public offering.</b>

AI Summary

Invech Holdings, Inc. (IVHI) filed a IPO Registration (S-1) with the SEC on January 30, 2024. Invech Holdings, Inc. has filed an S-1 registration statement with the SEC. The filing indicates the company is incorporated in Nevada. The company's primary SIC code is Pharmaceutical Preparations (2834). The principal executive offices are located in Scottsdale, AZ. The filing is related to a proposed sale of securities to the public on a delayed or continuous basis.

Why It Matters

For investors and stakeholders tracking Invech Holdings, Inc., this filing contains several important signals. This S-1 filing signals Invech Holdings' intention to become a publicly traded company or to offer additional shares. The registration statement provides potential investors with crucial information about the company's business, financials, and risks before any public sale.

Risk Assessment

Risk Level: low — Invech Holdings, Inc. shows low risk based on this filing. The filing is an S-1 registration statement, which is a preliminary step for a public offering and does not contain detailed financial performance data or operational specifics typical of later filings.

Analyst Insight

Monitor future filings for detailed financial statements and business operations to assess investment potential.

Key Numbers

  • 2834 — Standard Industrial Classification (Pharmaceutical Preparations)
  • 880419476 — IRS Number (Primary IRS Employer Identification No.)
  • 333-276779 — SEC File Number (SEC registration file number)
  • 24582073 — Film Number (SEC film number)

Key Players & Entities

  • Invech Holdings, Inc. (company) — Registrant
  • SEC (regulator) — Filing body
  • Nevada (company) — State of incorporation
  • 2834 (dollar_amount) — Standard Industrial Classification
  • Scottsdale, AZ (company) — Principal executive offices location
  • Pacific Stock Transfer Co. (company) — Agent for service
  • Rhonda Keaveney (person) — Correspondence contact

Forward-Looking Statements

  • Invech Holdings, Inc. will proceed with a public offering of securities. (Invech Holdings, Inc.) — high confidence, target: 2024-12-31

FAQ

When did Invech Holdings, Inc. file this S-1?

Invech Holdings, Inc. filed this IPO Registration (S-1) with the SEC on January 30, 2024.

What is a S-1 filing?

A S-1 is a registration statement for initial public offerings, containing the prospectus with business description, financials, and risk factors. This particular S-1 was filed by Invech Holdings, Inc. (IVHI).

Where can I read the original S-1 filing from Invech Holdings, Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Invech Holdings, Inc..

What are the key takeaways from Invech Holdings, Inc.'s S-1?

Invech Holdings, Inc. filed this S-1 on January 30, 2024. Key takeaways: Invech Holdings, Inc. has filed an S-1 registration statement with the SEC.. The filing indicates the company is incorporated in Nevada.. The company's primary SIC code is Pharmaceutical Preparations (2834)..

Is Invech Holdings, Inc. a risky investment based on this filing?

Based on this S-1, Invech Holdings, Inc. presents a relatively low-risk profile. The filing is an S-1 registration statement, which is a preliminary step for a public offering and does not contain detailed financial performance data or operational specifics typical of later filings.

What should investors do after reading Invech Holdings, Inc.'s S-1?

Monitor future filings for detailed financial statements and business operations to assess investment potential. The overall sentiment from this filing is neutral.

How does Invech Holdings, Inc. compare to its industry peers?

The company operates in the Pharmaceutical Preparations industry, indicated by its SIC code 2834.

Are there regulatory concerns for Invech Holdings, Inc.?

The filing is subject to the Securities Act of 1933 and requires adherence to SEC regulations for public offerings.

Risk Factors

  • Registration Statement Requirements [low — regulatory]: The company must comply with all SEC regulations and requirements for the S-1 filing and subsequent public offering.

Industry Context

The company operates in the Pharmaceutical Preparations industry, indicated by its SIC code 2834.

Regulatory Implications

The filing is subject to the Securities Act of 1933 and requires adherence to SEC regulations for public offerings.

What Investors Should Do

  1. Review the full S-1 filing for detailed business descriptions and risk factors.
  2. Track future SEC filings for financial performance updates.
  3. Monitor for news regarding the company's public offering timeline and details.

Key Dates

  • 2024-01-30T00:00:00.000Z: Filing Date — The date the S-1 registration statement was filed with the SEC.

Glossary

S-1
A registration statement filed with the SEC by companies intending to offer securities to the public. (Indicates the company's intent to go public or conduct a public offering.)
SIC Code
Standard Industrial Classification code used to classify business establishments. (Helps categorize the company's primary business activity.)
Rule 415
SEC rule allowing securities to be registered for delayed or continuous offerings. (Suggests the offering may not be immediate or could be ongoing.)

Year-Over-Year Comparison

This is an initial S-1 filing, so there is no prior filing to compare against for changes in financial or operational data.

Filing Stats: 4,512 words · 18 min read · ~15 pages · Grade level 13.8 · Accepted 2024-01-31 14:04:05

Key Financial Figures

  • $35,000 — ent (HK) Ltd. for the purchase price of $35,000. The Custodian did not receive any addi
  • $50,000 — Logistic Inc. for the purchase price of $50,000. Robert Chin, sole officer and director
  • $45,000 — mpliance, LLC for the purchase price of $45,000. These shares represent the majority co
  • $0.001 — 7,416 shares of common stock, par value $0.001 per share, of the Company (&ldquo;Resal

Filing Documents

RISK FACTORS

RISK FACTORS 5 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 13 DIVIDEND POLICY 13 MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS 14

USE OF PROCEEDS

USE OF PROCEEDS 14 DETERMINATION OF OFFERING PRICE 14

DILUTION

DILUTION 14 SELLING SECURITY HOLDERS 15 PLAN OF DISTRIBUTION-SELLING STOCKHOLDERS 20

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 23 LEGAL MATTERS 51 EXPERTS 51 INTERESTS OF NAMED EXPERTS AND COUNSEL 25 MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 26 DESCRIPTION OF BUSINESS 38 MARKET FOR OUR COMMON STOCK 41 DIRECTORS AND EXECUTIVE OFFICERS 42

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 47 DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES 50 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 48

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 49 WHERE YOU CAN FIND MORE INFORMATION 52 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS F-1 i ABOUT THIS PROSPECTUS You should rely only on the information contained in this prospectus or contained in any prospectus supplement or free writing prospectus filed with the Securities and Exchange Commission (the &ldquo; SEC &rdquo;). Neither we nor the selling stockholders have authorized anyone to provide you with additional information or information different from that contained in this prospectus filed with the SEC. The selling stockholders are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of shares of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date. For investors outside the United States: Neither we nor the selling stockholders have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside the United States. As used in this prospectus, unless otherwise designated, the terms &ldquo; we ,&rdquo; &ldquo; us ,&rdquo; &ldquo; our ,&rdquo; the &ldquo; Company ,&rdquo; &ldquo; IVHI &rdquo; and &ldquo; our Company &rdquo; refer to Invech Holdings, Inc., a Nevada corporation. ii CAUTION REGARDING FORWARD-LOOKING STATEMENTS This registration statement and the documents that are incorporated herein by reference

SUMMARY INFORMATION, RISK FACTORS AND RATIO OF EARNINGS TO FIXED CHARGES

ITEM 3. SUMMARY INFORMATION, RISK FACTORS AND RATIO OF EARNINGS TO FIXED CHARGES We and our business are subject to material risks, which could cause actual results, performance and achievements to differ materially from those anticipated, and the risk factors set forth in the section entitled &ldquo; Risk Factors &rdquo; beginning on page 5 of this prospectus. These risks can be summarized as follows: Business Related Risks &middot; We have incurred operating losses in some of our historical periods and we could incur additional losses until we successfully integrate acquired practices, improve collections for procedures and reduce operating expenses. &middot; Our capital resources may not be sufficient to meet our capital requirements, and in the absence of additional resources we may have to curtail or cease business operations. &middot; We may encounter substantial competition in the public company compliance consulting industry and our failure to compete effectively may adversely affect our ability to generate revenue. &middot; We may face a number of risks associated with our business services, including the possibility that we may incur substantial debt or convertible debt, which could adversely affect our financial condition. &middot; Our development will depend on the efforts of key management, key personnel and our relationships with operators and other partnerships. &middot; Our officers, directors and principal stockholders own a large percentage of our stock and other stockholders have little or no ability to elect directors or influence corporate matters. Risk Related to our Stock &middot; Our stock trades on an unsolicited basis only, so you may be unable to sell your shares at or near the quoted bid prices if you need to sell a significant number of your shares. &middot; Our common stock is defined as &ldquo;penny stock&rdquo; under the Exchange Act, and the rules promulgated thereunder. &middot; We may issue more shares in an

View Full Filing

View this S-1 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.